Eli Lilly and Company (LILY34) — Cash Flow-to-Debt Ratio
Eli Lilly and Company (LILY34) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of R$3.22 Billion could theoretically repay 0% of its total liabilities (R$85.94 Billion) in one year. Explore Eli Lilly and Company (LILY34) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Eli Lilly and Company Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Eli Lilly and Company across 12 annual periods. Also explore Eli Lilly and Company asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Eli Lilly and Company (2014–2025)
Year-by-year debt coverage analysis for Eli Lilly and Company. For market capitalisation and broader financial context, see Eli Lilly and Company (LILY34) total market value.
| Year | CF-to-Debt Ratio | Operating CF (BRL) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | R$16.81 Billion | R$85.94 Billion | ▲ +43.0% |
| 2024 | 0.14x | R$8.82 Billion | R$64.44 Billion | ▲ +27.3% |
| 2023 | 0.11x | R$5.71 Billion | R$53.14 Billion | ▼ -41.1% |
| 2022 | 0.18x | R$7.08 Billion | R$38.84 Billion | ▼ -0.4% |
| 2021 | 0.18x | R$7.26 Billion | R$39.65 Billion | ▲ +15.5% |
| 2020 | 0.16x | R$6.50 Billion | R$40.99 Billion | ▲ +20.2% |
| 2019 | 0.13x | R$4.84 Billion | R$36.68 Billion | ▼ -18.7% |
| 2018 | 0.16x | R$5.52 Billion | R$34.08 Billion | ▼ -3.6% |
| 2017 | 0.17x | R$5.62 Billion | R$33.39 Billion | ▼ -14.0% |
| 2016 | 0.20x | R$4.85 Billion | R$24.80 Billion | ▲ +38.4% |
| 2015 | 0.14x | R$2.96 Billion | R$20.98 Billion | ▼ -33.7% |
| 2014 | 0.21x | R$4.46 Billion | R$20.92 Billion | — |